International Trade Commission October 20, 2011 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoetin; Termination of Investigation on the Basis of Settlement
Notice is hereby given that the U.S. International Trade Commission has determined to terminate the above-captioned investigation on the basis of settlement between the private parties.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.